Login Register Cart 0
Generic placeholder image

Current Neurovascular Research

Editor-in-Chief

ISSN (Print): 1567-2026
ISSN (Online): 1875-5739

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Association between H-type Hypertension and White Matter Hyperintensity in Patients with Acute Ischemic Stroke

Author(s): Jiawei Yang, Zhiyong Cao, Jiahu Jiang, Yong Zhou and Xiangyang Zhu*

Volume 20, Issue 2, 2023

Published on: 05 June, 2023

Page: [190 - 196] Pages: 7

DOI: 10.2174/1567202620666230522153438

Price: $65

Abstract

Objective: White matter hyperintensity (WMH) is related to the increased risk of ischemic stroke. It is unclear if H-type hypertension (H-type HBP) is associated with periventricular WMH (PWMH) and deep WMH (DWMH) of acute ischemic stroke. This study investigated the correlation between H-type HBP and the severity of PWMH and DWMH in acute ischemic stroke.

Methods: Consecutive patients with acute ischemic stroke were included in this cross-sectional observational study. The patients were divided into the following groups: the normal group, the simple hypertension group (Simple HBP), the simple hyperhomocysteinemia group (Simple HHcy) and the H-type HBP group. MR imaging and relevant clinical variables were obtained from the medical records. PWMH and DWMH were rated by using the Fazekas scale (score 0-3). All patients were defined to have moderate-severe PWMH or DWMH (score 2-3) and no or mild group (score 0-1). Multivariate binary logistic regression analysis was performed to determine the relationship between H-type HBP and the severity of PWMH and DWMH.

Results: Among 542 patients, 227 had moderate-severe PWMH and 228 had moderate-severe DWMH. Compared to the no or mild group, patients with moderate-severe PWMH (median age: 73 vs. 63 years) and DWMH (median age: 70 vs. 65.5 years) were older. Compared to the no or mild group, moderate-severe PWMH and DWMH were associated with a history of ischemic stroke (moderate-severe PWMH vs. no or mild group 20.7% vs. 11.7%, p = 0.004；moderatesevere DWMH vs. no or mild group 20.2% vs. 12.1%, p = 0.010); We found that H-type HBP was an independent risk factor for PWMH (OR 2.64, 95% CI 1.34-5.21) and DWMH (OR 3.64, 95% CI 1.82-7.26) after adjusting for the effect of relevant risk factors.

Conclusion: This study suggests that H-type HBP is associated with the severity of PWMH and DWMH in acute ischemic stroke patients, which deserves further prevention measures.

« Previous Next »
[1]
Lam BYK, Yiu B, Ampil E, et al. High burden of cerebral white matter lesion in 9 Asian cities. Sci Rep 2021; 11(1): 11587.
[http://dx.doi.org/10.1038/s41598-021-90746-x] [PMID: 34078946]
[2]
Thurston RC, Wu M, Aizenstein HJ, et al. Sleep characteristics and white matter hyperintensities among midlife women. Sleep 2020; 43(6): zsz298.
[http://dx.doi.org/10.1093/sleep/zsz298] [PMID: 31863110]
[3]
Wang L, Lin H, Zhao Z, et al. Sex disparity of cerebral white matter hyperintensity in the hypertensive elderly: The Shanghai Changfeng study. Hum Brain Mapp 2023; 44(5): 2099-108.
[http://dx.doi.org/10.1002/hbm.26196] [PMID: 36583389]
[4]
Shao Y, Ruan J, Xu Y, Shu Z, He X. Comparing the performance of two radiomic models to predict progression and progression speed of white matter hyperintensities. Front Neuroinform 2021; 15: 789295.
[http://dx.doi.org/10.3389/fninf.2021.789295] [PMID: 34924990]
[5]
Yu F, Feng X, Li X, et al. Gut-derived metabolite phenylacetylglutamine and white matter hyperintensities in patients with acute ischemic stroke. Front Aging Neurosci 2021; 13: 675158.
[http://dx.doi.org/10.3389/fnagi.2021.675158] [PMID: 34393756]
[6]
Derraz I, Abdelrady M, Ahmed R, et al. Impact of white matter hyperintensity burden on outcome in large-vessel occlusion stroke. Radiology 2022; 304(1): 145-52.
[http://dx.doi.org/10.1148/radiol.210419] [PMID: 35348382]
[7]
Farag S, Kenawy FF, Shokri HM. The clinical characteristics of patients with pre-existing leukoaraiosis compared to those without leukoaraiosis in acute ischemic stroke. J Stroke Cerebrovasc Dis 2021; 30(9): 105956.
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2021.105956]
[8]
Meng F, Yang Y, Jin G. Research progress on mri for white matter hyperintensity of presumed vascular origin and cognitive impairment. Front Neurol 2022; 13: 865920.
[http://dx.doi.org/10.3389/fneur.2022.865920] [PMID: 35873763]
[9]
Qiu F, Chen C, Fan Z, Qiu J, Chen Q, Shao B. White Matter hypoperfusion associated with leukoaraiosis predicts intracranial hemorrhage after intravenous thrombolysis. J Stroke Cerebrovasc Dis 2021; 30(2): 105528.
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2020.105528]
[10]
Grosu S, Rospleszcz S, Hartmann F, et al. Associated factors of white matter hyperintensity volume: A machine-learning approach. Sci Rep 2021; 11(1): 2325.
[http://dx.doi.org/10.1038/s41598-021-81883-4] [PMID: 33504924]
[11]
Yu L, Yang L, Li Y, et al. Hyperhomocysteinemia can predict the severity of white matter hyperintensities in elderly lacunar infarction patients. Int J Neurosci 2020; 130(3): 231-6.
[http://dx.doi.org/10.1080/00207454.2019.1667795] [PMID: 31744348]
[12]
Zong X, Jimenez J, Li T, Powers WJ. In vivo detection of penetrating arteriole alterations in cerebral white matter in patients with diabetes with 7 T MRI. Magn Reson Imaging 2023; 100: 84-92.
[http://dx.doi.org/10.1016/j.mri.2023.03.015] [PMID: 36965833]
[13]
Gronewold J, Jokisch M, Schramm S, et al. Association of regional white matter hyperintensities with hypertension and cognition in the population‐based 1000BRAINS study. Eur J Neurol 2023; 30(5): 1174-90.
[http://dx.doi.org/10.1111/ene.15716] [PMID: 36702775]
[14]
Liang X, He T, Gao L, et al. Explore the Role of the rs1801133-PPARG Pathway in the H-type Hypertension. PPAR Res 2022; 2022: 1-7.
[http://dx.doi.org/10.1155/2022/2054876] [PMID: 35356087]
[15]
Chen Z, Wang F, Zheng Y, Zeng Q, Liu H. H-type hypertension is an important risk factor of carotid atherosclerotic plaques. Clin Exp Hypertens 2016; 38(5): 424-8.
[16]
Li T, Zhu J, Fang Q, et al. Association of h-type hypertension with stroke severity and prognosis. BioMed Res Int 2018; 2018: 8725908.
[http://dx.doi.org/10.1155/2018/8725908] [PMID: 30271787]
[17]
Zhang J, Liu Y, Wang A, et al. Association between H-type hypertension and asymptomatic extracranial artery stenosis. Sci Rep 2018; 8(1): 1328.
[http://dx.doi.org/10.1038/s41598-018-19740-0] [PMID: 29358636]
[18]
Zhang Y, Hou LS, Tang WW, et al. High prevalence of obesity-related hypertension among adults aged 40 to 79 years in Southwest China. Sci Rep 2019; 9(1): 15838.
[http://dx.doi.org/10.1038/s41598-019-52132-6] [PMID: 31676873]
[19]
Jin L, Guo X, Dou J, et al. Multimorbidity analysis according to sex and age towards cardiovascular diseases of adults in Northeast China. Sci Rep 2018; 8(1): 8607.
[http://dx.doi.org/10.1038/s41598-018-25561-y] [PMID: 29872063]
[20]
Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 1987; 149(2): 351-6.
[http://dx.doi.org/10.2214/ajr.149.2.351] [PMID: 3496763]
[21]
Nagaraja N, Farooqui A, Albayram MS. Association of deep white matter hyperintensity with left ventricular hypertrophy in acute ischemic stroke. J Neuroimaging 2022; 32(2): 268-72.
[http://dx.doi.org/10.1111/jon.12950] [PMID: 34861077]
[22]
Aggarwal NT, De Jager PL. Uncovering the genetic architecture of white matter disease. Ann Neurol 2011; 69(6): 907-8.
[http://dx.doi.org/10.1002/ana.22460] [PMID: 21681793]
[23]
Forsberg KME, Zhang Y, Reiners J, et al. Endothelial damage, vascular bagging and remodeling of the microvascular bed in human microangiopathy with deep white matter lesions. Acta Neuropathol Commun 2018; 6(1): 128.
[http://dx.doi.org/10.1186/s40478-018-0632-z] [PMID: 30470258]
[24]
Tarnaris A, Toma AK, Kitchen ND, Watkins LD. Ongoing search for diagnostic biomarkers in idiopathic normal pressure hydrocephalus. Biomarkers Med 2009; 3(6): 787-805.
[http://dx.doi.org/10.2217/bmm.09.37] [PMID: 20477715]
[25]
Jang H, Kang D, Chang Y, et al. Non-alcoholic fatty liver disease and cerebral small vessel disease in Korean cognitively normal individuals. Sci Rep 2019; 9(1): 1814.
[http://dx.doi.org/10.1038/s41598-018-38357-x] [PMID: 30755685]
[26]
Wu X, Zhang L, Miao Y, et al. Homocysteine causes vascular endothelial dysfunction by disrupting endoplasmic reticulum redox homeostasis. Redox Biol 2019; 20: 46-59.
[http://dx.doi.org/10.1016/j.redox.2018.09.021] [PMID: 30292945]
[27]
Mohammad G, Kowluru RA. Homocysteine disrupts balance between mmp-9 and its tissue inhibitor in diabetic retinopathy: The role of DNA methylation. Int J Mol Sci 2020; 21(5): 1771.
[http://dx.doi.org/10.3390/ijms21051771] [PMID: 32150828]
[28]
Hsu JL, Chen WH, Bai CH, et al. Microstructural white matter tissue characteristics are modulated by homocysteine: A diffusion tensor imaging study. PLoS One 2015; 10(2): e0116330.
[http://dx.doi.org/10.1371/journal.pone.0116330] [PMID: 25693199]
[29]
Li T, Liu X, Diao S, et al. H-type hypertension is a risk factor for cerebral small-vessel disease. BioMed Res Int 2020; 2020: 6498903.
[http://dx.doi.org/10.1155/2020/6498903] [PMID: 32090105]
[30]
Pang H, Han B, Fu Q, Zong Z. Association of high homocysteine levels with the risk stratification in hypertensive patients at risk of stroke. Clin Ther 2016; 38(5): 1184-92.
[http://dx.doi.org/10.1016/j.clinthera.2016.03.007] [PMID: 27021605]
[31]
Huang K, Zhang Z, Huang S, Jia Y, Zhang M, Yun W. The association between retinal vessel abnormalities and H-type hypertension. BMC Neurol 2021; 21(1): 6.
[http://dx.doi.org/10.1186/s12883-020-02029-z] [PMID: 33407217]
[32]
Qin X, Li Y, Sun N, et al. Elevated homocysteine concentrations decrease the antihypertensive effect of angiotensin-converting enzyme inhibitors in hypertensive patients. Arterioscler Thromb Vasc Biol 2017; 37(1): 166-72.
[http://dx.doi.org/10.1161/ATVBAHA.116.308515] [PMID: 27834686]
[33]
Challa F, Getahun T, Sileshi M, et al. Prevalence of Hyperhomocysteinaemia and Associated Factors among Ethiopian Adult Population in a 2015 National Survey. BioMed Res Int 2020; 2020: 9210261.
[http://dx.doi.org/10.1155/2020/9210261] [PMID: 32420383]
[34]
Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J 2015; 14(1): 6.
[http://dx.doi.org/10.1186/1475-2891-14-6] [PMID: 25577237]
[35]
Medrano-Martorell S, Capellades J, Jiménez-Conde J, et al. Risk factors analysis according to regional distribution of white matter hyperintensities in a stroke cohort. Eur Radiol 2022; 32(1): 272-80.
[http://dx.doi.org/10.1007/s00330-021-08106-2] [PMID: 34117555]
[36]
Zou Q, Wang M, Zhang D, Wei X, Li W. White matter hyperintensities in young patients from a neurological outpatient clinic: Prevalence, risk factors, and correlation with enlarged perivascular spaces. J Pers Med 2023; 13(3): 525.
[http://dx.doi.org/10.3390/jpm13030525] [PMID: 36983707]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy